ATAI
Price
$2.35
Change
-$0.14 (-5.62%)
Updated
Jun 3 closing price
Capitalization
498.84M
75 days until earnings call
XOMAO
Price
$25.20
Change
-$0.06 (-0.24%)
Updated
Jun 3 closing price
Capitalization
N/A
Interact to see
Advertisement

ATAI vs XOMAO

Header iconATAI vs XOMAO Comparison
Open Charts ATAI vs XOMAOBanner chart's image
ATAI Life Sciences
Price$2.35
Change-$0.14 (-5.62%)
Volume$2.56M
Capitalization498.84M
XOMA
Price$25.20
Change-$0.06 (-0.24%)
Volume$2.36K
CapitalizationN/A
ATAI vs XOMAO Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. XOMAO commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and XOMAO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ATAI: $2.35 vs. XOMAO: $25.20)
Brand notoriety: ATAI and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 127% vs. XOMAO: 49%
Market capitalization -- ATAI: $498.84M vs. XOMAO: $0
ATAI [@Biotechnology] is valued at $498.84M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAO is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 7 TA indicator(s) are bullish.

  • ATAI’s TA Score: 7 bullish, 4 bearish.

Price Growth

ATAI (@Biotechnology) experienced а +6.33% price change this week, while XOMAO (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.74%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was +0.73%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+5.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI YTD gains are higher at: 76.692 vs. XOMAO (2.359). XOMAO has higher annual earnings (EBITDA): -5.42M vs. ATAI (-124.33M). XOMAO has more cash in the bank: 93.3M vs. ATAI (85.9M). ATAI has less debt than XOMAO: ATAI (23.8M) vs XOMAO (119M). XOMAO has higher revenues than ATAI: XOMAO (10.2M) vs ATAI (331K).
ATAIXOMAOATAI / XOMAO
Capitalization499MN/A-
EBITDA-124.33M-5.42M2,293%
Gain YTD76.6922.3593,251%
P/E RatioN/AN/A-
Revenue331K10.2M3%
Total Cash85.9M93.3M92%
Total Debt23.8M119M20%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
37

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 30 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHDPX8.830.17
+1.96%
American Beacon Shapiro SMID Cap Eq Inv
CSSJX24.920.43
+1.76%
Carillon Chartwell Small Cap C
WLGAX36.13N/A
N/A
Macquarie Large Cap Growth Fund A
KTCCX13.60N/A
N/A
DWS Science and Technology C
AVEEX12.67N/A
N/A
Avantis® Emerging Markets Equity Instl

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.24%
AMLX - XOMAO
68%
Closely correlated
+0.39%
XOMAP - XOMAO
31%
Poorly correlated
-1.04%
ATAI - XOMAO
24%
Poorly correlated
-5.62%
LTRN - XOMAO
23%
Poorly correlated
+0.94%
KALV - XOMAO
23%
Poorly correlated
+3.33%
More